. Author manuscript; available in PMC: 2022 Aug 1.

Published in final edited form as: Breast Cancer Res Treat. 2021 Jun 26;189(1):187–202. doi: 10.1007/s10549-021-06307-3

Table 3.

Genes with variants occurring in at least 10% of the biomarker study population.

Gene symbol	Variant/N (%)	Non-pCR N=36 (%)	pCR N=20 (%)	p value
TP53	48 (85.7)	32 (88.7)	16 (80.0)	0.44
TTN	13 (23.2)	9 (25.0)	4 (20.0)	0.75
FLG	8 (14.3)	6 (16.7)	2 (10.0)	0.69
PCDHA1	7 (12.5)	7 (19.4)	0 (0.0)	0.04
TRMT9B	6 (10.7)	5 (13.9)	1 (5.0)	0.40
PCDHGA2	6 (10.7)	3 (8.3)	3 (15.0)	0.66
FAM135B	6 (10.7)	4 (11.1)	2 (10.0)	1.00
KIAA1671	6 (10.7)	4 (11.1)	2 (10.0)	1.00
SPEG	6 (10.7)	4 (11.1)	2 (10.0)	1.00
TENM1	6 (10.7)	4 (11.1)	2 (10.0)	1.00